Avalo Therapeutics (AVTX) Superinvestor holders
7 of the superinvestors we track hold Avalo Therapeutics (AVTX) in their latest 13F filings, $138M in total.
Summary
The largest holder is Tom Steyer (Farallon Capital Management LLC), with $46M, 0.3% of the portfolio.
In their latest quarter: 1 opened a new position, 5 added, 1 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Tom Steyer Farallon Capital Management LLC |
Added | 2,498,000 | $46M | 0.3% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Added | 2,387,026 | $44M | 0.1% | Q2 2026 |
| Wilmot Harkey Nantahala Capital Management |
Added | 1,862,250 | $34M | 2.1% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Added | 357,200 | $7M | 0.0% | Q2 2026 |
| Ken Fisher Fisher Investments |
New position | 316,505 | $5M | 0.0% | Q3 2026 |
| Two Sigma Two Sigma Investments |
Added | 67,094 | $1M | 0.0% | Q2 2026 |
| Man Group Man Group plc |
Trimmed | 36,876 | $681,468 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 6 |
| Q1 2026 | 9 |
| Q4 2025 | 8 |
| Q3 2025 | 5 |
| Q2 2025 | 2 |
| Q1 2025 | 1 |
| Q4 2024 | 1 |
| Q3 2023 | 1 |
Questions about Avalo Therapeutics
Which superinvestors own Avalo Therapeutics?
7 of the superinvestors we track hold Avalo Therapeutics (AVTX) in their latest 13F filings, $138M in total. Tom Steyer, Steve Cohen, Wilmot Harkey, Jim Simons, Ken Fisher, Two Sigma.
Who is the largest superinvestor holder of AVTX?
The largest holder is Tom Steyer (Farallon Capital Management LLC), with $46M, 0.3% of the portfolio.
From Avalo Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.